GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $27,000 | 0.0% | 624 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $27,000 | -3.6% | 624 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $28,000 | +16.7% | 624 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $24,000 | -7.7% | 624 | -3.9% | 0.01% | 0.0% |
| Q2 2021 | $26,000 | +13.0% | 649 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $23,000 | +155.6% | 649 | +159.6% | 0.01% | +200.0% |
| Q4 2020 | $9,000 | 0.0% | 250 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $9,000 | -10.0% | 250 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $10,000 | +11.1% | 250 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $9,000 | -43.8% | 250 | -28.6% | 0.00% | -40.0% |
| Q4 2019 | $16,000 | +6.7% | 350 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $15,000 | +7.1% | 350 | 0.0% | 0.01% | +25.0% |
| Q2 2019 | $14,000 | -75.0% | 350 | -74.1% | 0.00% | -75.0% |
| Q1 2019 | $56,000 | +330.8% | 1,350 | +285.7% | 0.02% | +300.0% |
| Q4 2018 | $13,000 | -40.9% | 350 | -36.4% | 0.00% | -42.9% |
| Q3 2018 | $22,000 | 0.0% | 550 | 0.0% | 0.01% | -12.5% |
| Q2 2018 | $22,000 | +4.8% | 550 | 0.0% | 0.01% | +14.3% |
| Q1 2018 | $21,000 | +5.0% | 550 | 0.0% | 0.01% | +16.7% |
| Q4 2017 | $20,000 | -9.1% | 550 | 0.0% | 0.01% | -14.3% |
| Q3 2017 | $22,000 | -8.3% | 550 | 0.0% | 0.01% | -12.5% |
| Q2 2017 | $24,000 | +4.3% | 550 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $23,000 | 0.0% | 550 | -8.3% | 0.01% | 0.0% |
| Q4 2016 | $23,000 | -11.5% | 600 | 0.0% | 0.01% | -11.1% |
| Q3 2016 | $26,000 | 0.0% | 600 | 0.0% | 0.01% | -10.0% |
| Q2 2016 | $26,000 | +8.3% | 600 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $24,000 | 0.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $24,000 | -14.3% | 600 | -17.2% | 0.01% | -16.7% |
| Q3 2015 | $28,000 | -6.7% | 725 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $30,000 | -9.1% | 725 | 0.0% | 0.01% | -7.7% |
| Q1 2015 | $33,000 | +6.5% | 725 | 0.0% | 0.01% | +18.2% |
| Q4 2014 | $31,000 | -6.1% | 725 | 0.0% | 0.01% | -8.3% |
| Q3 2014 | $33,000 | -25.0% | 725 | -12.1% | 0.01% | -20.0% |
| Q2 2014 | $44,000 | +33.3% | 825 | +32.0% | 0.02% | +25.0% |
| Q1 2014 | $33,000 | 0.0% | 625 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $33,000 | +6.5% | 625 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $31,000 | 0.0% | 625 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $31,000 | – | 625 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |